BEAMTREE HOLDINGS LIMITED — Capital/Financing Update 2025

Mar 23, 2025

==> picture [133 x 31] intentionally omitted <==

Beamtree Holdings Limited (ASX: BMT) ASX Announcement

Sydney, 24 March 2025

Strategic contract wins for Autonomous coding

Beamtree Holdings Limited (“ Beamtree ” or “ the Company ” or “the Group”) (ASX: BMT), a leading provider of AI decision support and data insights solutions for the healthcare sector, is pleased to announce that it has signed three new contracts across Australia, UK and Canada for the implementation of Beamtree’s new autonomous coding product with combined annual value of ~$0.6m. These contract wins provide evidence of the conversion of our sales pipeline outlined in our first half reporting. Each contract is subject to the usual rights of termination for non-performance.

Beamtree’s new autonomous coding software reduces hospital costs, improves revenue accuracy, and ensures fair reimbursement by automating the clinical coding process. Errors in data coding impact hospital reimbursements by an estimated $20bn globally.

These first wave contract wins mark an important strategic achievement for Beamtree, a world leader in clinical record coding technology, by demonstrating the demand for this breakthrough AI technology in three of its key geographical markets. The Company continues to develop its growing sales pipeline for autonomous coding and these contract wins provide a springboard and reference site for future sales.

Marek Stepniak, Beamtree CEO, said : “These three autonomous coding contract wins are an important achievement for Beamtree that support the innovative approach of the company and our focus on making our customers more efficient, thereby freeing up resources to focus on patient care. Autonomous coding will be a material driver of our future growth and these contract wins provide a foundation for this pioneering product. I want to thank our customers in supporting this innovation.”

Authorised for release by the Chair of the Board.

For further information, please email investor@beamtree.com.au

-ENDS-

About Beamtree

A leading provider of AI decision support and data insights solutions, Beamtree supports healthcare providers globally. They believe in creating a better future for health by turning data into insights and action through automation. They help solve real-world problems in healthcare by developing smart tools that aim to improve patient outcomes. Their solutions and services offer customers an unrivalled range of analytics across four key product segments:

• Diagnostic Technology : Enabling the effective delivery of diagnostic services as they underpin the future of health and personalised medicine.

• Clinical Decision Support: Combining human and artificial expertise together to enhance decisions that improve care, value and experience.

• Coding Assistance and Data Quality : Digitising and automating workflows with data, classification, coding & technical expertise to improve information standardisation, quality and timeliness.

• Analytics and Knowledge Networks : Combining data analytics solutions with peer-to-peer alliances that accelerate innovation and knowledge diffusion.

==> picture [68 x 7] intentionally omitted <==

Suite 2, Level 10 5 Blue Street North Sydney NSW 2016 ABN 42 627 071 121